‘Engage With Us,’ EMA Urges Psychedelic Drug Developers

Psychedelic drug developers are focusing on the US market, and there are no approvals in sight in the EU. The European Medicines Agency wants to change that.

psychedelic drugs
Psychedelic drugs include psilocybin which is found in so-called magic mushrooms • Source: Shutterstock

The European Medicines Agency is encouraging psychedelic drug developers to start targeting the market in the EU, where innovations for treating mental health diseases have stagnated for many years and such disorders have reached crisis levels.

“We are very keen on engaging with developers… and we welcome any application for marketing authorization independent of therapeutic area,”...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography